PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11258617-6	2001	A C5 propyne-modified phosphorothioate oligonucleotide (PS-ODN) targeted to the cytochrome p450-3A2 (CYP3A2) mRNA translational start site and the reverse sequence, used as a control, were synthesized.	methylacetylene	5-12	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	80-99	
11258617-6	2001	A C5 propyne-modified phosphorothioate oligonucleotide (PS-ODN) targeted to the cytochrome p450-3A2 (CYP3A2) mRNA translational start site and the reverse sequence, used as a control, were synthesized.	methylacetylene	5-12	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	101-107	
11258617-6	2001	A C5 propyne-modified phosphorothioate oligonucleotide (PS-ODN) targeted to the cytochrome p450-3A2 (CYP3A2) mRNA translational start site and the reverse sequence, used as a control, were synthesized.	Phosphorothioate Oligonucleotides	22-54	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	80-99	
11258617-6	2001	A C5 propyne-modified phosphorothioate oligonucleotide (PS-ODN) targeted to the cytochrome p450-3A2 (CYP3A2) mRNA translational start site and the reverse sequence, used as a control, were synthesized.	Phosphorothioate Oligonucleotides	22-54	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	101-107	
11258617-6	2001	A C5 propyne-modified phosphorothioate oligonucleotide (PS-ODN) targeted to the cytochrome p450-3A2 (CYP3A2) mRNA translational start site and the reverse sequence, used as a control, were synthesized.	ps-odn	56-62	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	80-99	
11258617-6	2001	A C5 propyne-modified phosphorothioate oligonucleotide (PS-ODN) targeted to the cytochrome p450-3A2 (CYP3A2) mRNA translational start site and the reverse sequence, used as a control, were synthesized.	ps-odn	56-62	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	101-107	
11258617-10	2001	Midozolam-treated animals with antisense to CYP3A2 slept significantly longer than did the controls (p < 0.05).	midozolam	0-9	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	44-50